Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALS untangled #83: clenbuterol.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

Ethics Roundtable: Prescribing Controlled Substances in a Terminally Ill Patient With Suspected Substance Abuse Disorder and Opioid Agreement Violations.

The American journal of hospice & palliative care·2026
Same author

ALSUntangled #80: ISRIB (Integrated stress response InhiBitor).

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025
Same author

ALSUntangled #78: Zinc.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025
Same author

Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications.

Muscle & nerve·2025
Same author

ALSUntangled #77: Psilocybin.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2024
Same journal

Explainable machine learning-based preliminary screening for viral encephalitis by blood routine analysis.

Frontiers in neurology·2026
Same journal

Global landscape of registered clinical trials of stem cell therapy for spinal cord injury: a cross-sectional analysis.

Frontiers in neurology·2026
Same journal

Experimental verification and PK/PD modeling of selective drug absorption via acupoint administration in rabbit model of rheumatoid arthritis.

Frontiers in neurology·2026
Same journal

Plasma metabolomic signatures of the no-reflow phenomenon in stroke patients following thrombectomy.

Frontiers in neurology·2026
Same journal

Parametric color-coding-derived microvascular transit time may predict infarction and reveals microcirculatory benefits of Tenecteplase in acute ischemic stroke.

Frontiers in neurology·2026
Same journal

The application of fNIRS-sEMG in the study of muscle-brain coupling.

Frontiers in neurology·2026
See all related articles

Related Experiment Video

Updated: Oct 24, 2025

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
09:49

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury

Published on: January 20, 2023

3.4K

Psychedelics for Brain Injury: A Mini-Review.

Mia Khan1, Gregory T Carter2, Sunil K Aggarwal3

  • 1Washington University School of Medicine in St. Louis, St. Louis, MO, United States.

Frontiers in Neurology
|August 16, 2021
PubMed
Summary
This summary is machine-generated.

Psychedelic therapeutics show promise for treating brain injuries like stroke and traumatic brain injury (TBI). Early research suggests these compounds may enhance neuroplasticity and reduce inflammation, offering new hope for neurorehabilitation.

Keywords:
brain injuryneuroinflammationneuroplasticitypsychedelicsreviewstroke

More Related Videos

Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury
10:59

Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury

Published on: November 19, 2012

15.5K
Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury
09:29

Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury

Published on: September 11, 2017

9.4K

Related Experiment Videos

Last Updated: Oct 24, 2025

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
09:49

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury

Published on: January 20, 2023

3.4K
Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury
10:59

Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury

Published on: November 19, 2012

15.5K
Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury
09:29

Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury

Published on: September 11, 2017

9.4K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurorehabilitation

Background:

  • Stroke and traumatic brain injury (TBI) are leading causes of severe disability.
  • Current pharmacologic treatments for brain injury remain limited.
  • Emerging research explores psychedelic therapeutics for brain injury.

Purpose of the Study:

  • To review the current scientific evidence on psychedelic therapeutics for brain injury.
  • To assess the relevance of this science to neurorehabilitation.
  • To provide a resource for understanding ongoing clinical trials.

Main Methods:

  • A narrative mini-review of published studies.
  • Focus on research linking psychedelic therapeutics and brain injury.

Main Results:

  • In vitro, in vivo, and case studies suggest potential benefits of psychedelic pharmacotherapies.
  • Mechanisms include modulation of neuroinflammation, neurogenesis, neuroplasticity, and brain complexity.
  • Historical safety data may support early-phase clinical trial designs.

Conclusions:

  • Psychedelic compounds show potential for treating brain injuries, including TBI and stroke-related reperfusion injury.
  • Further Phase II trials are needed to confirm efficacy.
  • This field represents a novel frontier in brain injury pharmacotherapy.